These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 23071587)
1. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma. Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587 [TBL] [Abstract][Full Text] [Related]
2. A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors. Edmond V; Merdzhanova G; Gout S; Brambilla E; Gazzeri S; Eymin B Cell Cycle; 2013 Apr; 12(8):1267-78. PubMed ID: 23518498 [TBL] [Abstract][Full Text] [Related]
3. Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. Edmond V; Moysan E; Khochbin S; Matthias P; Brambilla C; Brambilla E; Gazzeri S; Eymin B EMBO J; 2011 Feb; 30(3):510-23. PubMed ID: 21157427 [TBL] [Abstract][Full Text] [Related]
4. SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines. Edmond V; Brambilla C; Brambilla E; Gazzeri S; Eymin B Cell Cycle; 2011 Jun; 10(12):1968-77. PubMed ID: 21555914 [TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues. Boukakis G; Patrinou-Georgoula M; Lekarakou M; Valavanis C; Guialis A BMC Cancer; 2010 Aug; 10():434. PubMed ID: 20716340 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells. Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521 [TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway. Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052 [TBL] [Abstract][Full Text] [Related]
8. More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells. Zhang SY; Hui LP; Li CY; Gao J; Cui ZS; Qiu XS BMC Cancer; 2016 Feb; 16():171. PubMed ID: 26926340 [TBL] [Abstract][Full Text] [Related]
9. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma. Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer. Li X; Yang S; Zhang M; Xie S; Xie Z Eur J Histochem; 2019 Dec; 63(4):. PubMed ID: 31833327 [TBL] [Abstract][Full Text] [Related]
11. S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells. Wang R; Li Y; Hu E; Kong F; Wang J; Liu J; Shao Q; Hao Y; He D; Xiao X Oncotarget; 2017 Apr; 8(15):24804-24814. PubMed ID: 28177901 [TBL] [Abstract][Full Text] [Related]
12. Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma. Stojsic J; Stankovic T; Stojkovic S; Milinkovic V; Dinic J; Milosevic Z; Milovanovic Z; Tanic N; Bankovic J Exp Mol Pathol; 2015 Feb; 98(1):27-32. PubMed ID: 25449334 [TBL] [Abstract][Full Text] [Related]
13. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells. Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622 [TBL] [Abstract][Full Text] [Related]
14. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer. Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676 [TBL] [Abstract][Full Text] [Related]
15. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung. Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022 [TBL] [Abstract][Full Text] [Related]
16. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1. Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N Cells; 2019 Jan; 8(1):. PubMed ID: 30641926 [TBL] [Abstract][Full Text] [Related]
17. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231 [TBL] [Abstract][Full Text] [Related]
18. Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity. Kim CH; Kim YD; Choi EK; Kim HR; Na BR; Im SH; Jun CD J Biol Chem; 2016 Mar; 291(12):6169-81. PubMed ID: 26797131 [TBL] [Abstract][Full Text] [Related]
19. The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer. Moreno P; Lara-Chica M; Soler-Torronteras R; Caro T; Medina M; Álvarez A; Salvatierra Á; Muñoz E; Calzado MA PLoS One; 2015; 10(11):e0143376. PubMed ID: 26580787 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer. Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]